Implementing the National Heart, Lung, and Blood Institute's Strategic Vision in the Division of Cardiovascular Sciences

Writing Group for the Division of Cardiovascular Sciences’ Strategic Vision Implementation Plan, David C Goff Jr, Denis B Buxton, Gail D Pearson, Gina S Wei, Teri E Gosselin, Ebyan A Addou, Catherine M Stoney, Patrice Desvigne-Nickens, Pothur R Srinivas, Zorina S Galis, Charlotte Pratt, Kit Brian K Kit, Christine Maric-Bilkan, Holly L Nicastro, Renee P Wong, Vandana Sachdev, Jue Chen, Lawrence Fine, Writing Group for the Division of Cardiovascular Sciences’ Strategic Vision Implementation Plan, David C Goff Jr, Denis B Buxton, Gail D Pearson, Gina S Wei, Teri E Gosselin, Ebyan A Addou, Catherine M Stoney, Patrice Desvigne-Nickens, Pothur R Srinivas, Zorina S Galis, Charlotte Pratt, Kit Brian K Kit, Christine Maric-Bilkan, Holly L Nicastro, Renee P Wong, Vandana Sachdev, Jue Chen, Lawrence Fine

Abstract

As we commemorate the 70th Anniversary of the National Heart, Lung, and Blood Institute (NHLBI) and celebrate important milestones that have been achieved by the Division of Cardiovascular Sciences (DCVS), it is imperative that DCVS and the Extramural Research community at-large continue to address critical public health challenges that persist within the area of Cardiovascular Diseases (CVD). The NHLBI's Strategic Vision, developed with extensive input from the extramural research community and published in 2016, included overarching goals and strategic objectives that serve to provide a general blueprint for sustaining the legacy of the Institute by leveraging opportunities in emerging scientific areas (e.g., regenerative medicine, omics technology, data science, precision medicine, and mobile health), finding new ways to address enduring challenges (e.g., social determinants of health, health inequities, prevention, and health promotion), and training the next generation of heart, lung, blood, and sleep researchers. DCVS has developed a strategic vision implementation plan to provide a cardiovascular framing for the pursuit of the Institute's overarching goals and strategic objectives garnered from the input of the broader NHLBI community. This plan highlights six scientific focus areas that demonstrate a cross-cutting and multifaceted approach to addressing cardiovascular sciences, including 1) addressing social determinants of cardiovascular health (CVH) and health inequities, 2) enhancing resilience, 3) promoting CVH and preventing CVD Across the lifespan, 4) eliminating hypertension-related CVD, 5) reducing the burden of heart failure, and 6) preventing vascular dementia. These priorities will guide our efforts in Institute-driven activities in the coming years but will not exclude development of other novel ideas or the support of investigator-initiated grant awards. The DCVS Strategic Vision implementation plan is a living document that will evolve with iterative dialogue with the NHLBI community and adapt as the dynamic scientific landscape changes to seize emerging opportunities.

Keywords: Cardiovascular Disease; Cardiovascular health; Health equity; Heart Failure; Hypertension; National Heart, Lung, and Blood Institute; Resilience; Strategic Vision; Vascular dementia.

Conflict of interest statement

Disclosures: None of the authors have relationships with industry or conflicts of interest to disclose. The views expressed in this article are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; National Institutes of Health; or the United States Department of Health and Human Services.

References

    1. National Heart L, and Blood Institute. Charting the Future Together. The NHLBI STrategic Vision 2016; . Accessed June 1, 2018.
    1. Benjamin EJ, Virani SS, Callaway CW, et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation 2018;137(12):e67–e492.
    1. Sidney S, Quesenberry CP Jr., Jaffe MG, Sorel M, Go AS, Rana JS Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000–2015. BMC Cardiovasc Disord 2017;17(1):192.
    1. Roth GA, Dwyer-Lindgren L, Bertozzi-Villa A, et al. Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980–2014. JAMA 2017;317(19):1976–1992.
    1. Viner RM, Ozer EM, Denny S, et al. Adolescence and the social determinants of health. The Lancet 2012;379(9826):1641–1652.
    1. Havranek EP, Mujahid MS, Barr DA, et al. Social Determinants of Risk and Outcomes for Cardiovascular Disease. A Scientific Statement From the American Heart Association 2015;132(9):873–898.
    1. Artiga S, Hinton Elizabeth. Beyond Health Care: The Role of Social Determinants in Promoting Health and Health Equity May 2018.
    1. Pool LR, Ning H, Lloyd-Jones DM, Allen NB. Trends in Racial/Ethnic Disparities in Cardiovascular Health Among US Adults From 1999–2012. J Am Heart Assoc 2017;6(9).
    1. Schultz WM, Kelli HM, Lisko JC, et al. Socioeconomic Status and Cardiovascular Outcomes. Challenges and Interventions 2018;137(20):2166–2178.
    1. Murray CJ, Kulkarni SC, Michaud C, et al. Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med 2006;3(9):e260.
    1. Bhatnagar A Environmental Determinants of Cardiovascular Disease. Circulation research 2017;121(2):162–180.
    1. National Heart Lung and Blood Institute. Notice of Intent to Publish a Funding Opportunity Announcement for Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) 2018; . Accessed 7/19/2018, 2018.
    1. National Institutes of Health. Common Data Element (CDE) Resource Portal 2016; . Accessed 12/14/2018, 2018.
    1. National Heart Lung and Blood Institute. New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trial Not Allowed) 2018; . Accessed 12/14/2018, 2018.
    1. Windle G, Bennett KM, Noyes J. A methodological review of resilience measurement scales. Health and quality of life outcomes 2011;9:8.
    1. Friend SH, Schadt EE. Translational genomics. Clues from the resilient. Science 2014;344(6187):970–972.
    1. Fuster V The Power of Resilience. Journal of the American College of Cardiology 2014;64(8):840–842.
    1. Mailman MD, Feolo M, Jin Y, et al. The NCBI dbGaP database of genotypes and phenotypes. Nature genetics 2007;39(10):1181–1186.
    1. Thornburg KL. The programming of cardiovascular disease. Journal of developmental origins of health and disease 2015;6(5):366–376.
    1. Allen NB, Ning H, Lloyd Jones D, Zhao L, Siddique J. Abstract P196: Cardiovascular Health Across the Lifespan: The Development and Validation of a Synthetic Cardiovascular Cohort. Circulation 2017;135(Suppl 1): AP196–AP196.
    1. Gillman MW. Primordial prevention of cardiovascular disease. Circulation 2015;131(7):599–601.
    1. Yeboah J Road to the American Heart Association 2020 Impact Goals. The Metric for Monitoring Progress 2018;11(1).
    1. Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation 2010;121(4):586–613.
    1. Karmali KN, Lloyd-Jones DM. Achieving and Maintaining Cardiovascular Health Across the Lifespan. Current Epidemiology Reports 2014;1(2):75–81.
    1. National Institutes of Health. Adolescent Brain Cognitive Development Study 2018; . Accessed July 19, 2018, 2018.
    1. National Institutes of Health. Environmental Influences on Child Health Outcomes . Accessed 07/18/2018, 2018.
    1. National Institutes of Environmental Health Sciences. Children’s Health Exposure Analysis Resource (CHEAR) 2018; .
    1. Hardy ST, Loehr LR, Butler KR, et al. Reducing the Blood Pressure–Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control. Journal of the American Heart Association 2015;4(10).
    1. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet 2016;387(10022):957–967.
    1. Appel LJ. Lifestyle modification as a means to prevent and treat high blood pressure. Journal of the American Society of Nephrology : JASN 2003;14(7 Suppl 2):S99–s102.
    1. Dorans KS, Mills KT, Liu Y, He J. Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline. J Am Heart Assoc 2018;7(11).
    1. Whelton PK, Carey RM, Aronow WS, et al. 2017. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2018;71(19):e127–e248.
    1. Victor RG, Lynch K, Li N, et al. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med 2018;378(14):1291–1301.
    1. Egan BM, Li J, Wagner CS. Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines. Hypertension 2016;68(2):318–323.
    1. Appel LJ, Sacks FM, Carey VJ, et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. Jama 2005;294(19):2455–2464.
    1. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997;336(16):1117–1124.
    1. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344(1):3–10.
    1. Dunlay SM, Roger VL. Understanding the epidemic of heart failure: past, present, and future. Current heart failure reports 2014;11(4):404–415.
    1. Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev 2017;3(1):7–11.
    1. Joyce E, Givertz MM. Turning Failure into Success: Trials of the Heart Failure Clinical Research Network. Current Cardiology Reports 2016;18(12):121.
    1. Corriveau RA, Koroshetz WJ, Gladman JT, et al. Alzheimer's Disease–Related Dementias Summit 2016: National research priorities. Neurology 2017;89(23):2381.
    1. Dichgans M, Leys D. Vascular Cognitive Impairment. Circulation research 2017;120(3):573–591.
    1. Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta neuropathologica 2017;134(2):171–186.
    1. Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary Costs of Dementia in the United States. New England Journal of Medicine 2013;368(14):1326–1334.
    1. Goodman RA, Lochner KA, Thambisetty M, Wingo TS, Posner SF, Ling SM. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011–2013. Alzheimer’s & dementia : the journal of the Alzheimer’s Association 2017;13(1):28–37.
    1. Doubal FN, Ali M, Batty GD, et al. Big data and data repurposing - using existing data to answer new questions in vascular dementia research. BMC neurology 2017;17(1):72.
    1. Froehlich TE, Bogardus ST Jr., Inouye SK Dementia and race: are there differences between African Americans and Caucasians? J Am Geriatr Soc 2001;49(4):477–484.
    1. National Heart L, and Blood Institute. FY 2018. Funding and Operating Guidelines 2018; . Accessed June 1, 2018.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する